The Truth about Statins: Risks and Alternatives to Cholesterol-Lowering Drugs (Mass Market Paperbound)
Risks and Alternatives to Cholesterol-Lowering Drugs
Pocket Books, 9781451656398, 288pp.
Publication Date: April 24, 2012
From an award-winning cardiologist comes the most up-to-date, definitive reference book about statins--cholesterol-lowering drugs--providing a thorough examination of the uses and safety claims of this high-profile class of drugs. COULD STATIN DRUGS ACTUALLY HARM YOU? Despite the rosy picture painted in the ads of a miracle cure for high cholesterol and its attendant heart disease, the reality of taking statins may be far less pretty. Dr. Barbara H. Roberts, director of the Women's Cardiac Center at the Miriam Hospital in Rhode Island, discusses both the benefits and health risks of these popular drugs in this comprehensive guide that finally reveals the questionable science behind the research studies. This honest, patient-friendly appraisal of the most widely used medications in the world may shock you, but it may also save your life. Offering clear-cut, easy-to-understand information in an easily accessible fashion, Dr. Roberts explains how to take the best possible care of your heart, including: * The keys to maintaining cardiovascular well-being * How to interpret your cholesterol numbers * The frightening adverse effects of popular drugs It is time to take charge of your heart health. Learn the facts behind the hype so that you can make informed decisions on a subject vital to your continued health. If you or someone you love either takes a statin or is considering doing so, you need to read this book. Includes recipes for a delicious and heart-healthy diet, including Wasabi-Roasted Salmon, Pasta with Avocado Sauce, and Lemon-Pineapple Breakfast Muffins.
About the Author
Barbara H. Roberts, M.D., is Director of The Women's Cardiac Center at the Miriam Hospital in Providence, Rhode Island. She is also an Associate Clinical Professor of Medicine at the Alpert Medical School of Brown University. She spent two years at the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) where she was involved in the first clinical trial that demonstrated a beneficial effect of lowering cholesterol on the incidence of heart disease. She is currently a principal investigator in another NIH-sponsored trial of cholesterol-lowering therapy.